Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2024 - 2026)
Lucid Diagnostics (LUCD) reported Other Non-Current Liabilities of $25.2 million for Q1 2026, up 35.48% quarter-over-quarter from $18.6 million in Q4 2024.
Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends
Lucid Diagnostics has reported Other Non-Current Liabilities for 2 years, with the latest figure at $25.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $25.2 million; the trailing twelve-month figure through Mar 2026 stood at $25.2 million (changed N/A YoY), and the FY2024 full-year result was $18.6 million, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $25.2 million, up from $18.6 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $25.2 million in Q1 2026, with the low at $18.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.20 Mn |
| Dec 31, 2024 | 18.60 Mn |